2 stocks to watch for their explosive growth
In recent years, we have seen staggering growth from pharmaceutical giants such as Novo Nordisk, which has achieved over 350% returns thanks to the popularity of weight loss and diabetes drugs. If you haven't caught up with this growth, don't despair. The stock market always offers new opportunities that can deliver market-beating returns.
Today, we'll take a look at two interesting companies in the healthcare sector that have the potential to bring investors significant gains over the long term.
CRISPR Therapeutics: a breakthrough in gene therapy
CRISPR Therapeutics $CRSP has a long-standing focus on developing and commercializing gene therapies using CRISPR technology, which enables DNA editing to offer potential treatments for genetic diseases. While its development has been slow and investors have waited patiently for product approval from regulatory authorities, the company is now on the cusp of its first significant commercial success. It recently received FDA approval for its…
The $HIMS looks very good and the business intrigues me. Overall, the company is doing very well. But I don't know if now is a good time to buy. The stock isn't cheap, but it doesn't seem super overpriced to me either.